Biblio Discovery — Demo Discovery Service

4 hasil untuk "Adam Mor"

Menampilkan 1–4 · 0,97 detik · RSS

  1. Artikel Jurnal Teks lengkap

    A novel mouse model for checkpoint inhibitor-induced adverse events

    Kieran Adam; Alina Iuga; Anna S. Tocheva dkk.

    PLOS ONE, Vol. 16 No. 2 · 2021 · Inggris · PLOS Scopus

    Immune checkpoint inhibitors have demonstrated significant efficacy in the treatment of a variety of cancers, however their therapeutic potential is limited by abstruse immune related adverse events. Currently, no robust animal model exists of checkpoint inhibitor-induced adverse events…

  2. Artikel Jurnal Teks lengkap

    Structure-Function Analysis of Nucleolin and ErbB Receptors Interactions

    Keren Farin; Ayelet Di Segni; Adam Mor dkk.

    PLoS ONE, Vol. 4 No. 7 · 2009 · Inggris · PLOS Scopus

    Background: The ErbB receptor tyrosine kinases and nucleolin are major contributors to malignant transformation. Recently we have found that cell-surface ErbB receptors interact with nucleolin via their cytoplasmic tail. Overexpression of ErbB1 and nucleolin leads to receptor phosphorylation…

  3. Artikel Jurnal Teks lengkap

    SLAMF6 clustering is required to augment T cell activation

    Matthew A. Dragovich; Kieran Adam; Marianne Strazza dkk.

    PLOS ONE, Vol. 14 No. 6 · 2019 · Inggris · PLOS Scopus

    The signaling lymphocytic activation molecule (SLAM) family is comprised of nine distinct receptors that are expressed exclusively on hematopoietic cells. Most of these transmembrane receptors are homotypic by nature and downstream signaling occurs when cells that express the same SLAM receptor…

  4. Artikel Jurnal Teks lengkap

    Mesencephalic astrocyte-derived neurotrophic factor is secreted from interferon-γ–activated tumor cells through ER calcium depletion

    Michael Peled; Tali H. Bar-Lev; Efrosiniia Talalai dkk.

    PLOS ONE, Vol. 16 No. 4 · 2021 · Inggris · PLOS Scopus

    The most successful immunotherapeutic agents are blocking antibodies to either programmed cell death-1 (PD-1), an inhibitory receptor expressed on T lymphocytes, or to its ligand, programmed cell death-ligand 1 (PD-L1). Nevertheless, many patients do not respond, and additional approaches…